-
Lantheus Announces FDA Grants PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
30 Oct 2025 12:30 GMT
… Injection, indicated for use with positron emission tomography (PET) imaging for localization of … kit indicated for use with positron emission tomography (PET) for localization of somatostatin …
-
Football hits leave lasting brain changes
30 Oct 2025 11:37 GMT
… the validity of this diagnosis. Positron emission tomography (PET) promises to help detect …
-
Blood test breakthrough could transform Alzheimer’s diagnosis
30 Oct 2025 02:35 GMT
… the current gold standards using positron emission tomography scans and lumbar punctures.
BioWorld …
-
<![CDATA[FAQs On The Critical Window Hypothesis for Menopausal Hormone Therapy's Neuroprotective Effects ]]>
29 Oct 2025 18:11 GMT
… use with tau and β‑amyloid positron emission tomography. JAMA Neurol. 2023;80(5 …
-
Online Brain Training Reverses 10 Years of Aging in Memory and Learning
29 Oct 2025 13:14 GMT
… Acetylcholine Transporter Levels using Fluoroethoxybenzovesamicol Positron Emission Tomography in Healthy Older Adults: Results …
-
A Review on the Applications of Artificial Intelligence for Diagnosing and Treating Cervical Cancer
29 Oct 2025 12:35 GMT
… (CT), magnetic resonance (MR), and positron emission tomography (PET) images, on the basis … deep learning from 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Eur Radiol …
-
Football Players Show Subtle Brain Differences Linked to CTE Risk
29 Oct 2025 02:16 GMT
… encephalopathy pathology, neuropsychological performance, and positron emission tomography imaging using flortaucipir.
We analysed …
-
How Meditation Replicates the Astronauts' 'Overview Effect'
28 Oct 2025 16:58 GMT
… results from 78 fMRI/positron emission tomography (PET) meditation studies and found …
-
<![CDATA[Late Hepatic Recurrence From Granulosa Cell Tumor: A Case Report]]>
28 Oct 2025 16:13 GMT
… . [18F]FDG and [18F]FES positron emission tomography for disease monitoring and assessment …
-
Lantheus Announces FDA Acceptance of New Drug Application for MK-6240, a PET Imaging Agent Targeting Tau in Alzheimer’s Disease
28 Oct 2025 12:30 GMT
… investigational F18-labeled tau-targeted Positron Emission Tomography (PET) imaging agent for the …